Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cardiovascular Effects of Carbetocin During Elective Caesarean Delivery: A Randomized Controlled Trial Comparing Infusion Versus Bolus Administration Using Nexfin™

NCT02636816 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.

NCT NCT02636816
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02636816 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cardiovascular Effects of Carbetocin During Elective Caesarean Delivery: A Randomized Controlled Trial Comparing Infusion Versus Bolus Administration Using Nexfin™
Lead sponsor
University of British Columbia
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2016
Completion date
June 30, 2016
Enrollment
57 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

effect of carbetocin on cardiovascular system, pregnancy